Summary

Report Scope
The diagnostics industry has grown despite the challenging economic conditions in recent years. The industry draws much attention and scrutiny from the public and government, and is currently undergoing many changes due to increased focus on regulations. These changes can be seen across many countries. The U.S., the largest diagnostics market, is leading the trend with changes intended to make healthcare more affordable. Opportunities for the diagnostics industry are manifold, with the appearance of new markets located mainly in emerging economies with varying needs.
Increasing healthcare expenditures and the growth of emerging economies have increased the demand for technologically better diagnostic devices, kits, reagents, and other accessories. Additionally, the introduction of more stringent regulations, specifically in the developed markets of the U.S. and Europe, has forced diagnostics manufacturers to launch advanced products that include new materials, a focus on in-depth indications, and the ability to produce additional new data.
Some of the major driving factors in the market are the increasing prevalence of chronic and infectious diseases, technological advances in diagnostics, increasing investments in AI in the diagnostics market, increased applications in non-oncology areas, and growing adoption of personalized medicine.
Furthermore, technically sophisticated diagnostics are needed for clinical research, as the market is highly competitive, and companies must continuously reinvent their product portfolios to enter new markets and place themselves as key participants in the healthcare system. There is a shift toward a value-based healthcare market where price and purchase decisions are based on outcomes. This has further led to increased scrutiny of device technology, and consequently, the degree of competition has risen. Some of the major firms in the diagnostics market include Abbott, Medtronic, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Agilent Technologies Inc., QIAGEN, Danaher Corp., Sysmex, Thermo Fisher Scientific Inc., BD, and others.
The diagnostics industry is a multi-billion-dollar market with an outlook for continued growth in the coming years. Hospital care is growing, and the diagnostics industry is being looked at to provide low-cost technology for home healthcare. Now, the industry seeks healthcare diagnostic devices, kits, and reagents that individuals with unskilled healthcare experience can use. The need for modern technology, equipment, and devices can be leveraged through diagnostic equipment as manufacturers seek to create better-quality healthcare solutions.
The above reasons are compelling enough to analyze and research the diagnostics market, as the market has tremendous growth potential.
It includes highlights from these reports published in 2024:
- MDS051B Tissue Diagnostics: Technologies and Global Markets
- HLC300A Global Colorectal Cancer Screening and Diagnostics Market
- MDS046B Oncology Diagnostics: Global Markets
- BIO150E Liquid Biopsy Research Tools, Services, and Diagnostics
- BIO151B Human Microbiome-based Drugs and Diagnostics
- BIO063F Molecular Diagnostics: Technologies and Global Markets
- HLC186D In Vitro Diagnostics: Technologies and Global Markets
- PHM026D Global Markets for Allergy Diagnostics and Treatments
- HLC197B Noninvasive Cancer Diagnostics: Technologies and Global Markets
- HLC029G Global Markets for Diabetes Therapeutics and Diagnostics
After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Foreword
Research Review Scope
Chapter 2 Tissue Diagnostics: Technologies and Global Markets (MDS051B)
Market Outlook
Scope of Report
Market Summary
Market Overview and Definitions
Immunohistochemistry (IHC)
In Situ Hybridization
Polymerase Chain Reaction
Next-Generation Sequencing
General Culture Testing
Market Dynamics
Market Drivers
Market Opportunities
Market Restraints
Market Challenges
Emerging Technologies and Developments
Market Breakdown
Market Breakdown by Product Type
Market Breakdown by Segment
Histopathology Market
Molecular Pathology Market
Microbiology Testing Market
Digital Pathology Market
Market Breakdown by Region
North America
Europe
Asia-Pacific
Latin America
Rest of the World
Sustainability in the Market for Tissue Diagnostics: An ESG Perspective
Introduction to ESG
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 3 Global Colorectal Cancer Screening and Diagnostics Market (HLC300A)
Market Outlook
Scope of Report
Market Insights
Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies
Global Market for Colorectal Cancer Screening and Diagnostic Testing Services
Market Analysis by Test Type
Colonoscopy and Sigmoidoscopy Tests
Stool DNA Tests
Blood-Based/Biomarker Tests
Fecal Occult Blood Tests (FOBT)
Fecal Immunochemical Tests (FIT)
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Sustainability in the Colorectal Cancer Screening and Diagnostic Testing Service Market
Introduction
Sustainability
Concluding Remarks from BCC
Chapter 4 Oncology Diagnostics: Global Markets (MDS046B)
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Strategic Initiatives
Conclusion
Market Overview
Market Dynamics
Market Drivers
Market Opportunities
Market Restraints
Market Challenges
Emerging Technologies
Global Market Insights
Market Breakdown by Product Type
Diagnostics Imaging
Endoscopy Devices
Tumor Biomarker Tests
Biopsy Devices
Hematoxylin and Eosin
Immunohistochemistry
In situ Hybridization
Polymerase Chain Reaction
Next-Generation Sequencing
Others
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa (MEA)
Sustainability in the Market for Oncology Diagnostics: An ESG Perspective
Introduction to ESG
ESG Performance Analysis
Concluding Remarks from BCC
Chapter 5 Liquid Biopsy Research Tools, Services and Diagnostics (BIO150E)
Market Outlook
Scope of Report
Market Summary
Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies
Market Trends
Global Market for Liquid Biopsy by Application
Non-invasive Prenatal Testing (NIPT)
Cancer
Organ Transplantation
Global Market for Liquid Biopsy by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Sustainability in the Liquid Biopsy Market: ESG Perspective
Introduction to ESG
ESG Practices in the Liquid Biopsy Industry
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks from BCC Research
Chapter 6 Human Microbiome-based Drugs and Diagnostics (BIO151B)
Market Outlook
Scope of Report
Market Summary
Market Dynamics
Emerging Technologies
Analysis by Segment
Regional Analysis
Conclusion
Overview and Market Definition
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies
Market Analysis by Type
Microbiome-based Drugs
Microbiome-based Diagnostics
Market Analysis by Region
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Sustainability in the Human Microbiome-based Drugs and Diagnostics Industry: An ESG Perspective
Introduction to ESG
ESG Risk Ratings
Concluding Remarks
Chapter 7 Molecular Diagnostics: Technologies and Global Markets (BIO063F)
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies
Market Analysis by Technology
Key Takeaways
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
In Situ Hybridization
Microarrays
Others
Market Analysis by Product and Service
Key Takeaways
Consumables
Instruments
Software and Services
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Sustainability in the Molecular Diagnostics Market: An ESG Perspective
Introduction to ESG
ESG Practices in the Molecular Diagnostics Industry
ESG Risk Ratings
Conclusion
Chapter 8 In Vitro Diagnostics: Technologies and Global Markets (HLC186D)
Market Outlook
Scope of Report
Market Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies in the IVD Market
Market Analysis by Technology
Immunochemistry
POC Testing
Hematology
Molecular Diagnostics
Tissue Diagnostics
Clinical Microbiology
Market Analysis by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
Importance of ESG in In Vitro Diagnostics Manufacturing Industry
ESG Practices in the In Vitro Diagnostics Industry
Environmental Performance
Social Performance
Governance Performance
Company Role in ESG Development
ESG Risk Ratings
BCC Research Viewpoint
Chapter 9 Global Markets for Allergy Diagnostics and Treatments (PHM026D)
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Segmental Analysis
Regional Analysis
Conclusion
Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies
Global Allergy Diagnostics and Treatment Market by Type
Key Takeaways
Diagnostics
Treatments
Global Allergy Diagnostics and Treatment Market by Drug Type
Key Takeaways
Prescription Drugs
Over-the-Counter Drugs
Global Allergy Diagnostics and Treatment Market by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America
Sustainability in the Allergy Diagnostics and Treatment Market:ESG Perspective
Introduction to ESG
Role of ESG in the Allergy Diagnostics and Treatment Market
ESG Risk Ratings
Conclusion
Chapter 10 Noninvasive Cancer Diagnostics: Technologies and Global Markets (HLC197B)
Market Outlook
Scope of the Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Current Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Emerging Technologies
Market Analysis by Cancer Type
Key Takeaways
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Stomach Cancer
Liver Cancer
Esophageal Cancer
Bladder Cancer
All Other Cancers
Market Analysis by Technology Type
Key Takeaways
Diagnostic Imaging Technologies
Advanced Noninvasive Approaches
Conventional Noninvasive Cancer Screening, Diagnostic Assays and Tests
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Sustainability in Global Noninvasive Cancer Diagnostics Market: An ESG Perspective
Introduction to ESG
Major Manufacturers: ESG Efforts
Concluding Remarks from BCC Research
Chapter 11 Global Markets for Diabetes Therapeutics and Diagnostics (HLC029G)
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Technological Advances
Conclusion
Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Emerging Technologies
Global Diabetes Therapeutics and Diagnostic Market by Product
Key Takeaways
Diabetes Therapeutics
Diabetes Monitoring Devices and Accessories
Insulin Delivery Devices
Global Diabetes Therapeutics and Diagnostic Market by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Sustainability in the Diabetes Therapeutics and Diagnostics Market: An ESG Perspective
Introduction to ESG
ESG in Diabetes Therapeutics and Diagnostics
ESG Performance Analysis
Concluding Remarks from BCC
Chapter 12 Appendix
Methodology
Analyst’s Credentials

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1 : Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 2 : Global Incidence of All Cancers, by Region, 2022-2045
Table 3 : Cancer Cases, by Country, 2022
Table 4 : Incidence of Cancer, by Cancer Type, 2022
Table 5 : Global Tissue Diagnostics Market, Through 2029
Table 6 : Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 7 : Global Tissue Diagnostics Market, by Segment Type, Through 2029
Table 8 : Global Tissue Diagnostics Market, by Region, Through 2029
Table 9 : ESG: Environmental Overview
Table 10 : ESG: Social Overview
Table 11 : ESG: Governance Overview
Table 12 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 13 : Countries with Highest Colorectal Cancer Incidence and Rates, 2022
Table 14 : Successful Colorectal Cancer Screening Initiatives, 2004-2011
Table 15 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, Through 2029
Table 16 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 17 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 18 : Recent ESG Highlights from Select Testing Services Providing Companies
Table 19 : ESG Rankings for a Few Service-Providing Companies, 2024
Table 20 : ESG Rankings for Major Product Manufacturing Companies, 2024
Table 21 : Global Market for Oncology Diagnostics, by Product Type, Through 2029
Table 22 : Cancer Treatments Based on Specific Tests
Table 23 : Select FDA-Approved AI-Associated/Associable-Equipped Medical Devices
Table 24 : Global Oncology Diagnostics Market, by Product Type, Through 2029
Table 25 : Global Oncology Diagnostics Market, by Region, Through 2029
Table 26 : ESG: Environmental Overview
Table 27 : ESG: Social Overview
Table 28 : ESG: Governance Overview
Table 29 : Global Market for Liquid Biopsy, by Region, Through 2029
Table 30 : Liquid Biopsy Sample Types and Characteristics
Table 31 : Global Market for Liquid Biopsy, by Application, Through 2029
Table 32 : Global Market for Liquid Biopsy, by Region, Through 2029
Table 33 : Key Focus Areas in ESG Metrics
Table 34 : Environmental Performance Initiatives in the Liquid Biopsy Market
Table 35 : Social Performance Initiatives in the Liquid Biopsy Market
Table 36 : Governance Performance Initiatives in the Liquid Biopsy Market
Table 37 : ESG Rankings for Leaders in the Market for Liquid Biopsy, 2024*
Table 38 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Region, Through 2030
Table 39 : Diseases Associated with Microbiome Dysbiosis
Table 40 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Type, Through 2030
Table 41 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Region, Through 2030
Table 42 : ESG Goals of Human Microbiome-based Drugs and Diagnostics Companies
Table 43 : ESG Risk Ratings for Human Microbiome-based Drugs and Diagnostics Firms, 2025
Table 44 : Global Molecular Diagnostics Market, by Region, Through 2030
Table 45 : Global Molecular Diagnostics Market, by Technology, Through 2030
Table 46 : Global Molecular Diagnostics Market, by Product and Service, Through 2030
Table 47 : Global Molecular Diagnostics Market, by Region, Through 2030
Table 48 : Environmental Performance Initiatives in the Molecular Diagnostics Market
Table 49 : Social Performance Initiatives in the Molecular Diagnostics Market
Table 50 : Governance Performance Initiatives in the Molecular Diagnostics Market
Table 51 : ESG Risk Rankings for Molecular Diagnostics Companies, 2025
Table 52 : Global Market for In Vitro Diagnostics, by Region, Through 2029
Table 53 : Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 54 : Summary of Electrochemiluminescence POCT Devices with Their Analytic Performance
Table 55 : Global Market for In Vitro Diagnostics, by Region, Through 2029
Table 56 : ESG Practices: Environmental Performance
Table 57 : ESG Practices: Social Performance
Table 58 : ESG Practices: Governance Performance
Table 59 : Creating an Attractive Workplace: Social Performance
Table 60 : ESG Rankings for Leading In Vitro Diagnostics Companies, 2023 and 2024*
Table 61 : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
Table 62 : Global Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 63 : Global Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 64 : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
Table 65 : ESG Risk Rankings for Allergy Diagnostic and Treatment Market Companies, 2025*
Table 66 : Global Market for Noninvasive Cancer Diagnostics, by Region, Through 2030
Table 67 : Types of Liquid Biopsy and Their Clinical Applications, 2024
Table 68 : Estimated Cancer Incidence, Age (0-85+), 2022–2045
Table 69 : Estimated Cancer Incidence in Males in the U.S., by Cancer Site, 2025
Table 70 : Estimated Cancer Incidence in Females in the U.S., by Cancer Site, 2025
Table 71 : Global Market for Noninvasive Cancer Diagnostics, by Cancer Type, Through 2030
Table 72 : Global Market for Noninvasive Cancer Diagnostics, by Technology Type, Through 2030
Table 73 : Global Market for Noninvasive Cancer Diagnostics, by Region, Through 2030
Table 74 : ESG Highlights, by Major Players, 2024
Table 75 : Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2030
Table 76 : Indonesia: Price Ranges of Diabetes Monitoring Products, by Sector, 2024
Table 77 : Selected Technology Integrated Products
Table 78 : Global Market for Diabetes Therapeutics and Diagnostics, by Product, Through 2030
Table 79 : Global Revenues of Leading Diabetes-Focused Pharmaceutical Companies,2023 and 2024
Table 80 : Major Companies: Diabetes Therapeutic Pipeline
Table 81 : Insulin vs. GLP-1 Therapy
Table 82 : Standard GLP-1 RAs vs. Dual/Triple Agonists
Table 83 : Comparison of Different Types of Insulins
Table 84 : Oral Antidiabetic Drugs Overview
Table 85 : Blood Glucose Test Strips, by Manufacturer
Table 86 : Blood Glucose Meters, by Manufacturer
Table 87 : Continuous Glucose Monitoring Systems, by Manufacturer
Table 88 : Comparison of Continuous Glucose Monitoring Systems, by Company
Table 89 : Lancets and Lancet Devices, by Manufacturer
Table 90 : Insulin Infusion Pumps, by Manufacturer
Table 91 : Insulin Pen, by Manufacturer
Table 92 : Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2030
Table 93 : Diabetes Waste Management Recommendations
Table 94 : ESG Rankings for Diabetes Therapeutics and Diagnostics Companies, 2025*
Table 95 : ESG: Environmental Overview
Table 96 : ESG: Social Overview
Table 97 : ESG: Governance Overview